295 related articles for article (PubMed ID: 32371069)
41. Enhanced anticancer activity of drug nanoparticles formulated with β-cyclodextrin.
Zhan H; Jagtiani T; Liang JF
Anticancer Drugs; 2017 Mar; 28(3):271-280. PubMed ID: 27926611
[TBL] [Abstract][Full Text] [Related]
42. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
43. Bioreducible block copolymers based on poly(ethylene glycol) and poly(γ-benzyl L-glutamate) for intracellular delivery of camptothecin.
Thambi T; Yoon HY; Kim K; Kwon IC; Yoo CK; Park JH
Bioconjug Chem; 2011 Oct; 22(10):1924-31. PubMed ID: 21899345
[TBL] [Abstract][Full Text] [Related]
44. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
[TBL] [Abstract][Full Text] [Related]
45. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
46. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
[TBL] [Abstract][Full Text] [Related]
47. Codelivery of doxorubicin and camptothecin by dual-responsive unimolecular micelle-based β-cyclodextrin for enhanced chemotherapy.
Gao YE; Bai S; Ma X; Zhang X; Hou M; Shi X; Huang X; Chen J; Wen F; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2019 Nov; 183():110428. PubMed ID: 31415956
[TBL] [Abstract][Full Text] [Related]
48. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
[TBL] [Abstract][Full Text] [Related]
49. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
[TBL] [Abstract][Full Text] [Related]
50. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
51. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
[TBL] [Abstract][Full Text] [Related]
52. CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT.
Du F; Meng H; Xu K; Xu Y; Luo P; Luo Y; Lu W; Huang J; Liu S; Yu J
Colloids Surf B Biointerfaces; 2014 Jan; 113():230-6. PubMed ID: 24096159
[TBL] [Abstract][Full Text] [Related]
53. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
54. Fabrication of biodegradable micelles with sheddable poly(ethylene glycol) shells as the carrier of 7-ethyl-10-hydroxy-camptothecin.
Guo Q; Luo P; Luo Y; Du F; Lu W; Liu S; Huang J; Yu J
Colloids Surf B Biointerfaces; 2012 Dec; 100():138-45. PubMed ID: 22766290
[TBL] [Abstract][Full Text] [Related]
55. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y
Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070
[TBL] [Abstract][Full Text] [Related]
56. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
57. Design, preparation and characterization of pH-responsive prodrug micelles with hydrolyzable anhydride linkages for controlled drug delivery.
Seetharaman G; Kallar AR; Vijayan VM; Muthu J; Selvam S
J Colloid Interface Sci; 2017 Apr; 492():61-72. PubMed ID: 28068545
[TBL] [Abstract][Full Text] [Related]
58. Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting.
Omar R; Bardoogo YL; Corem-Salkmon E; Mizrahi B
J Control Release; 2017 Jul; 257():76-83. PubMed ID: 27677603
[TBL] [Abstract][Full Text] [Related]
59. Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Liu C; Yuan J; Luo X; Chen M; Chen Z; Zhao Y; Li X
Mol Pharm; 2014 Nov; 11(11):4258-69. PubMed ID: 25238329
[TBL] [Abstract][Full Text] [Related]
60. Encapsulation and Controlled Release of a Camptothecin Prodrug from Nanocarriers and Microgels: Tuning Release Rate with Nanocarrier Excipient Composition.
Wilson BK; Sinko PJ; Prud'homme RK
Mol Pharm; 2021 Mar; 18(3):1093-1101. PubMed ID: 33440941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]